FDA Drug Application (202217) for PEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL by NOVEL LABS INC

Back to FDA Applications sponsored by NOVEL LABS INC

Application Number202217
Product Number001
FormFOR SOLUTION, TABLET, DELAYED RELEASE;ORAL
Dosage5MG,N/A;N/A,210GM;N/A,0.74GM;N/A,2.86GM;N/A,5.6GM
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePEG-3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE AND BISACODYL
Active IngredientBISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE



Back to FDA Applications sponsored by NOVEL LABS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.